The Viz Vascular Suite allows vascular care teams to identify and triage care for suspected vascular diseases. Credit: aodaodaodaod / Shutterstock.com.

Provider of artificial intelligence (AI)-powered disease detection and intelligent care coordination Viz.ai has rolled out its Viz Vascular Suite.

An AI-backed software, the Viz Vascular Suite allows vascular care teams to automatically identify and triage care for suspected pulmonary embolism, aortic dissection, right heart strain and abdominal aortic aneurysm (AAA).

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Viz.ai has filed a new 510(k) application with the US Food & Drug Administration (FDA) for the AAA algorithm.

Leveraging AI, the software analyses a host of imaging modalities automatically, including computerised tomography (CT), electrocardiogram (ECG) and more for suspected vascular diseases.

If a suspected pathology is found, the app automatically sends out an alert and shows high-fidelity patient scans on the mobile device of providers.

See Also:

Clinicians will be able to use the Viz Vascular Suite to coordinate vascular pathology care remotely within the hub and spoke network of a hospital system. It also helps provide synchronous, HIPAA-compliant communication among specialists.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

This end-to-end platform for vascular care teams is improved by AI with a view to enabling immediate team activation and facilitating informed, efficient decisions regarding treatments.

Viz.ai CEO Chris Mansi said: “We set out to build a solution where any patient with life-threatening diseases can benefit from AI-powered care coordination with triage and real-time mobile communication. The Viz Vascular Suite will bring the advantages of intelligent care coordination to even more patients and help clinical teams achieve better clinical outcomes.”

“The feedback from our early adopters has been highly positive, and we look forward to expanding access to this solution to our over 1,300 hospital customer base.”